UNITY BIOTECHNOLOGY INC.
2.21
USD
(+8.33%)
04/03/2025 - 11:02
Open 15 min delayed data - NASDAQ Stocks
| Open: | 2.04 |
| Change: | +0.17 |
| Volume: | 4,533 |
| Low: | 2.04 |
| High: | 2.33 |
| High / Low range: | 0.29 |
| Type: | Stocks |
| Ticker: | UBX |
| ISIN: |
UNITY BIOTECHNOLOGY INC. news, videos and press releases
For more news please use our advanced search feature.
UNITY BIOTECHNOLOGY INC. - More news...
UNITY BIOTECHNOLOGY INC. - More news...
- 03/24/2025 - 11:01 UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
- 03/23/2025 - 20:00 UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025
- 03/10/2025 - 12:00 UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors
- 03/07/2025 - 21:30 UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
- 01/07/2025 - 21:10 UNITY Biotechnology Reports Granting of New Employment Inducement Award
- 01/06/2025 - 13:00 UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
- 11/04/2024 - 21:30 UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
- 09/24/2024 - 12:00 UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024
- 08/12/2024 - 12:00 UNITY Biotechnology to Participate in Upcoming Investor Conferences
- 08/06/2024 - 20:30 UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates
- 07/24/2024 - 12:00 UNITY Biotechnology Reports Granting of New Employment Inducement Award
- 07/22/2024 - 12:00 UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer
- 05/14/2024 - 21:00 UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
- 04/25/2024 - 12:00 UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
- 04/23/2024 - 12:00 UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
- 04/15/2024 - 11:00 UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
- 02/06/2024 - 13:00 New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
- 12/12/2023 - 13:00 UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME
- 11/13/2023 - 21:05 UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates
- 11/10/2023 - 13:00 UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
- 09/27/2023 - 11:00 UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
- 08/08/2023 - 20:05 UNITY Biotechnology, Inc. Reports Second Quarter 2023 Financial Results and Business Updates
- 06/21/2023 - 11:00 UNITY Announces Design of Phase 2b ASPIRE Study Evaluating UBX1325 in Diabetic Macular Edema (DME)
- 04/24/2023 - 11:00 UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
- 04/23/2023 - 22:00 UNITY Biotechnology to Host Program Update on BEHOLD, the Phase 2 Clinical Trial of UBX1325 in Patients with Diabetic Macular Edema
- 03/27/2023 - 11:30 UNITY Biotechnology Announces Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
- 03/15/2023 - 20:05 UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
- 02/28/2023 - 21:05 UNITY Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
- 02/09/2023 - 13:00 UNITY Biotechnology to Host Investor Call to Review Data from the UBX1325 Program and Provide an Overview of the ENVISION Wet AMD Study
- 01/18/2023 - 13:00 UNITY Biotechnology Reports Granting of New Employment Inducement Award
